A new study reveals that many perceived benefits of gluten-free products, such as weight control and diabetes management, are ...

Pfizer has made the decision to discontinue the clinical development program for danuglipron, an oral GLP-1 receptor agonist, being investigated for chronic weight management.

The prevalence of irritable bowel syndrome and chronic idiopathic constipation rose significantly during the COVID-19 pandemic.

Incidental BE was common and associated with high-risk features that were similar to or more severe than those found in BE diagnosed by traditional methods.

Hormone diets have taken off on social media as the latest weight loss trend, but their scientific validity remains ...

HealthDay News — The viability of hospital-based emergency care in the United States is at risk, according to a RAND report released April 7.

Adverse pregnancy outcomes mediate a small proportion of the association between prepregnancy obesity and CVD risk in midlife.

Overall cancer mortality rates declined from 2001-2022; cancer incidence rates decreased from 2001-2013 and stabilized through 2021.

PBGENE-HBV is designed to potentially cure chronic hepatitis B by eliminating the root cause of the virus. The Food and Drug Administration (FDA) has granted Fast Track designation to PBGENE-HBV, an ...

In a study of adults with diabetes and gastrointestinal (GI) motility abnormalities, over 75% had GI motility abnormalities.

The Trump administration is weighing a plan to cut nearly a third of the federal health budget and eliminate dozens of programs.

The FDA has approved a tablet form of Livmarli (maralixibat) for cholestatic pruritus in patients with Alagille syndrome and progressive familial intrahepatic cholestasis.